BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36308352)

  • 21. Comorbidities in lung cancer.
    Dutkowska AE; Antczak A
    Pneumonol Alergol Pol; 2016; 84(3):186-92. PubMed ID: 27238182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Not only cigarettes - other culprits of lung cancer.
    Grzywa-Celińska A; Drogoń I; Emeryk-Maksymiuk J; Chmielewska I; Milanowski J
    Ann Agric Environ Med; 2019 Dec; 26(4):661-664. PubMed ID: 31885242
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diagnosis and therapy of chronic obstructive pulmonary disease--recommendations of the Polish Phtisiopneumonology Society].
    Kozielski J; Chazan R; Gorecka D; Jahnz-Rozyk K; Jedrychowski W; Kuna P; Malolepszy J; Pierzchala W; Pirozynski M; Plusa T; Slominski JM; Sliwiniski P; Zielinski J
    Pneumonol Alergol Pol; 2002; 70 Suppl 2():2-42. PubMed ID: 12661329
    [No Abstract]   [Full Text] [Related]  

  • 24. COPD and lung cancer among women: an equal opportunity risk?
    Mannino DM
    J Thorac Oncol; 2009 Mar; 4(3):275-6. PubMed ID: 19247079
    [No Abstract]   [Full Text] [Related]  

  • 25. Update in lung cancer 2007.
    Dubey S; Powell CA
    Am J Respir Crit Care Med; 2008 May; 177(9):941-6. PubMed ID: 18434333
    [No Abstract]   [Full Text] [Related]  

  • 26. Tuberculosis, smoking and risk for lung cancer incidence and mortality.
    Hong S; Mok Y; Jeon C; Jee SH; Samet JM
    Int J Cancer; 2016 Dec; 139(11):2447-55. PubMed ID: 27521774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An epidemiological study of risk factors for lung cancer in Guangzhou, China.
    Du YX; Cha Q; Chen XW; Chen YZ; Huang LF; Feng ZZ; Wu XF; Wu JM
    Lung Cancer; 1996 Mar; 14 Suppl 1():S9-37. PubMed ID: 8785671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung cancer risk among smokers of menthol cigarettes.
    Blot WJ; Cohen SS; Aldrich M; McLaughlin JK; Hargreaves MK; Signorello LB
    J Natl Cancer Inst; 2011 May; 103(10):810-6. PubMed ID: 21436064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors shared by COPD and lung cancer and mediation effect of COPD: two center case-control studies.
    Yang L; Lu X; Deng J; Zhou Y; Huang D; Qiu F; Yang X; Yang R; Fang W; Ran P; Zhong N; Zhou Y; Fang S; Lu J
    Cancer Causes Control; 2015 Jan; 26(1):11-24. PubMed ID: 25488825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future lung cancer incidence in Poland and Finland based on forecasts on hypothetical changes in smoking habits.
    Didkowska J; Wojciechowska U; Koskinen HL; Tavilla A; Dyba T; Hakulinen T
    Acta Oncol; 2011 Jan; 50(1):81-7. PubMed ID: 20553096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study.
    Park HY; Kang D; Shin SH; Yoo KH; Rhee CK; Suh GY; Kim H; Shim YM; Guallar E; Cho J; Kwon OJ
    Thorax; 2020 Jun; 75(6):506-509. PubMed ID: 32241883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The link between chronic obstructive pulmonary disease phenotypes and histological subtypes of lung cancer: a case-control study.
    Wang W; Xie M; Dou S; Cui L; Zheng C; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1167-1175. PubMed ID: 29695900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for lung cancer in Iowa women: implications for prevention.
    Neuberger JS; Mahnken JD; Mayo MS; Field RW
    Cancer Detect Prev; 2006; 30(2):158-67. PubMed ID: 16581199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a lung cancer risk prediction model for African-Americans.
    Etzel CJ; Kachroo S; Liu M; D'Amelio A; Dong Q; Cote ML; Wenzlaff AS; Hong WK; Greisinger AJ; Schwartz AG; Spitz MR
    Cancer Prev Res (Phila); 2008 Sep; 1(4):255-65. PubMed ID: 19138969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Inhaled Corticosteroids and the Risk of Lung Cancer, the HUNT Study.
    Sørli K; Thorvaldsen SM; Hatlen P
    Lung; 2018 Apr; 196(2):179-184. PubMed ID: 29427221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of smoking-cessation pharmacotherapy among chronic obstructive pulmonary disease (COPD) and lung cancer patients.
    Vaidya V; Hufstader-Gabriel M; Gangan N; Shah S; Bechtol R
    Curr Med Res Opin; 2014 Jun; 30(6):1043-50. PubMed ID: 24432816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
    Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
    Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.
    Hopkins RJ; Duan F; Chiles C; Greco EM; Gamble GD; Aberle D; Young RP
    Ann Am Thorac Soc; 2017 Mar; 14(3):392-402. PubMed ID: 28076701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The respiratory effects of smoking].
    Peiffer G; Underner M; Perriot J
    Rev Pneumol Clin; 2018 Jun; 74(3):133-144. PubMed ID: 29793770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case-control study of lung cancer with special reference to the effect of air pollution in Poland.
    Jedrychowski W; Becher H; Wahrendorf J; Basa-Cierpialek Z
    J Epidemiol Community Health; 1990 Jun; 44(2):114-20. PubMed ID: 2370498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.